147 related articles for article (PubMed ID: 35067783)
1. STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression.
Zhu W; Sheng D; Shao Y; Zhang Q; Peng Y
Mol Cell Biochem; 2022 Mar; 477(3):865-875. PubMed ID: 35067783
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Xie Y; Gu J; Qin Z; Ren Z; Wang Y; Shi H; Chen B
Cell Biochem Funct; 2020 Dec; 38(8):1006-1016. PubMed ID: 32430927
[TBL] [Abstract][Full Text] [Related]
3. MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a.
Zhang S; Li Z; Zhang L; Xu Z
Mol Med Rep; 2018 Jul; 18(1):202-208. PubMed ID: 29749452
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2.
Chen Y; Gu M; Liu C; Wan X; Shi Q; Chen Q; Wang Z
Gene; 2019 Feb; 686():37-42. PubMed ID: 30389560
[TBL] [Abstract][Full Text] [Related]
5. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.
Takayama K; Horie-Inoue K; Katayama S; Suzuki T; Tsutsumi S; Ikeda K; Urano T; Fujimura T; Takagi K; Takahashi S; Homma Y; Ouchi Y; Aburatani H; Hayashizaki Y; Inoue S
EMBO J; 2013 Jun; 32(12):1665-80. PubMed ID: 23644382
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/
Liu C; Lin P; Zhao J; Xie H; Li R; Yang X; Wang N; Jia H; Jiang S; Zhang K; Yu X
Epigenomics; 2021 Oct; 13(20):1591-1605. PubMed ID: 34657447
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA BLACAT1 inhibits prostate cancer cell proliferation through sponging miR-361.
Li HY; Jiang FQ; Chu L; Wei X
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):74-85. PubMed ID: 31957820
[TBL] [Abstract][Full Text] [Related]
8. High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling.
Xi X; Hu Z; Wu Q; Hu K; Cao Z; Zhou J; Liao J; Zhang Z; Hu Y; Zhong X; Bao Y
Bioengineered; 2022 Jan; 13(1):1895-1907. PubMed ID: 35030969
[TBL] [Abstract][Full Text] [Related]
9. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
[TBL] [Abstract][Full Text] [Related]
10. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer.
Wang Q; Liu J; You Z; Yin Y; Liu L; Kang Y; Li S; Ning S; Li H; Gong Y; Xu S; Pang D
Cell Death Dis; 2021 Jan; 12(1):83. PubMed ID: 33446634
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.
Yacqub-Usman K; Pickard MR; Williams GT
Prostate; 2015 May; 75(7):693-705. PubMed ID: 25650269
[TBL] [Abstract][Full Text] [Related]
13. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
14. LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression.
Zhu F; Zhang X; Yu Q; Han G; Diao F; Wu C; Zhang Y
J Cell Biochem; 2018 Jun; 119(6):4496-4505. PubMed ID: 29231261
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.
Dallavalle C; Albino D; Civenni G; Merulla J; Ostano P; Mello-Grand M; Rossi S; Losa M; D'Ambrosio G; Sessa F; Thalmann GN; Garcia-Escudero R; Zitella A; Chiorino G; Catapano CV; Carbone GM
J Clin Invest; 2016 Dec; 126(12):4585-4602. PubMed ID: 27820701
[TBL] [Abstract][Full Text] [Related]
16. NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1.
Jing Z; Liu Q; Xie W; Wei Y; Liu J; Zhang Y; Zuo W; Lu S; Zhu Q; Liu P
Cell Signal; 2022 Apr; 92():110265. PubMed ID: 35085770
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway.
Xiong W; Huang C; Deng H; Jian C; Zen C; Ye K; Zhong Z; Zhao X; Zhu L
Int J Biochem Cell Biol; 2018 Jan; 94():125-132. PubMed ID: 29225160
[TBL] [Abstract][Full Text] [Related]
18. MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.
Dai H; Wang C; Yu Z; He D; Yu K; Liu Y; Wang S
Cancer Biother Radiopharm; 2018 Apr; 33(3):103-109. PubMed ID: 29641255
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
Fan H; Li J; Wang J; Hu Z
Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
[TBL] [Abstract][Full Text] [Related]
20. A long noncoding RNA connects c-Myc to tumor metabolism.
Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
